Review: taking Viibryd and Cymbalta together


Summary

Drug interactions are reported among people who take Viibryd and Cymbalta together. This review analyzes the effectiveness and drug interactions between Viibryd and Cymbalta. It is created by eHealthMe based on reports of 72 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Viibryd and Cymbalta >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Viibryd

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. (latest outcomes from Viibryd 3,828 users)

Cymbalta

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. (latest outcomes from Cymbalta 58,912 users)

On Aug, 26, 2016

72 people who take Viibryd, Cymbalta are studied.


Number of reports submitted per year:

Viibryd and Cymbalta drug interactions.

Drug effectiveness over time:

Viibryd:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 3 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Cymbalta:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Viibryd:
  • female: 0.0% - (0 of 9 people)
  • male: 0.0% - (0 of 0 people)
Cymbalta:
  • female: 11.0% - (1 of 9 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Viibryd:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 5 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Cymbalta:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 4 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • depression
  • dystonia
  • pain in extremity
  • diarrhoea
  • nausea
  • insomnia
  • poor quality sleep
  • self injurious behaviour
  • tearfulness
  • confusional state
1 - 6 months:
  • suicidal ideation
  • acne
  • cold intolerance
  • depression
  • diarrhoea
  • dizziness
  • dizziness exertional
  • drug ineffective
  • exaggerated startle response
  • headache
6 - 12 months:
  • feeling abnormal
  • headache
  • hypoaesthesia oral
  • nausea
  • depressed mood
  • malaise
  • migraine
  • dizziness
  • depression
  • diarrhoea
1 - 2 years:
  • dizziness exertional
  • exaggerated startle response
  • hypoglycaemia
  • startle reflex
2 - 5 years:
  • pancytopenia
  • hypoglycaemia
5 - 10 years:
  • cold intolerance
not specified:
  • completed suicide
  • depression
  • diarrhoea
  • hyperhidrosis
  • cardio-respiratory arrest
  • hyperthermia
  • nausea
  • overdose
  • fatigue
  • tremor

Most common drug interactions by gender *:

female:
  • depression
  • diarrhoea
  • nausea
  • dizziness
  • syncope
  • suicidal ideation
  • fatigue
  • headache
  • acne
  • insomnia
male:
  • completed suicide
  • cardio-respiratory arrest
  • hyperhidrosis
  • hyperthermia
  • overdose
  • dystonia
  • pain in extremity
  • bradycardia
  • depression
  • hypotension

Most common drug interactions by age *:

30-39:
  • dystonia
  • pain in extremity
  • convulsion
  • depression
  • insomnia
  • nausea
  • vomiting
  • abdominal abscess
  • abdominal distension
  • abdominal pain
40-49:
  • diarrhoea
  • fatigue
  • acne
  • headache
  • suicidal ideation
  • anaemia
  • anxiety
  • autoimmune hepatitis
  • depression
  • dizziness
50-59:
  • completed suicide
  • cardio-respiratory arrest
  • hyperhidrosis
  • hyperthermia
  • nausea
  • overdose
  • depression
  • diarrhoea
  • bradycardia
  • hypotension
60+:
  • depression
  • angina pectoris
  • back pain
  • blood creatinine increased
  • bone density decreased
  • bone pain
  • diabetic nephropathy
  • diabetic retinopathy
  • glomerular filtration rate decreased
  • hand fracture

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Viibryd and Cymbalta?

Can you answer these questions?

More questions for: Viibryd, Cymbalta

You may be interested in these reviews

More reviews for: Viibryd, Cymbalta

On eHealthMe, Viibryd (vilazodone hydrochloride) is often used to treat depression. Cymbalta (duloxetine hydrochloride) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.